1. Abrams JS, Rayner AA, Wiernik PH. High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma. J Natl Cancer Inst 1990;82:1202.
2. Amato RJ. Chemotherapy for renal cell carcinoma. Semin Oncol 2000;27:177–186.
3. Amato RJ, Murray L, and Wood L. Active specific immunotherapy in patients with renal cell carcinoma (RCC) using autologous tumor derived heat shock protein-peptide complex-96 (HSPP-96) vaccine. Proc Am Soc Clin Oncol 1999;Abstract 19.
4. Angevin E, Kremer F, Gaudin C. Analysis of T-cell immune response in renal cell carcinoma: polarization to type I-like differentiation pattern, clonal T-cell expansion, and tumor-specific cyto-toxicity. Int J Cancer 1997;72:431–440.
5. Aulitzky W, Gastl G, Aulitzky WE et al. Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma. J Clin Oncol 1989;7:1875–1884.